The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026. Mumbai: Novartis India’s board has approved the acquisition of the Minipress and Minipres trademarks registered in India from Pfizer Inc and Pfizer Products Inc for Rs 1,250 crore.The deal also covers certain intellectual property rights linked to the brands, the company said in an exchange filing.Following the approval, Novartis India signed an asset purchase agreement and trademark assignment deeds with the two Pfizer entities. Key points and original sources are listed below.

• The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026.S1

• Mumbai: Novartis India’s board has approved the acquisition of the Minipress and Minipres trademarks registered in India from Pfizer Inc and Pfizer Products Inc for Rs 1,250 crore.The deal also covers certain intellectual property rights linked to the brands,...S2